scholarly journals Surgical Treatment for Benign Bone Tumors and Tumorous Lesions of Femur.

1993 ◽  
Vol 42 (1) ◽  
pp. 409-410
Author(s):  
Takeshi Minamizaki ◽  
Makoto Okuno ◽  
Mitsuru Nakagawa ◽  
Kichizo Yamamoto
2018 ◽  
Vol 35 (04) ◽  
pp. 324-332 ◽  
Author(s):  
Roberto Cazzato ◽  
Andrew Gilkison ◽  
Jean Caudrelier ◽  
Julien Garnon ◽  
Afshin Gangi ◽  
...  

AbstractBenign bone tumors consist of a wide variety of neoplasms that do not metastasize but can still cause local complications. Historical management of these tumors has included surgical treatment for lesion resection and possible mechanical stabilization. Initial percutaneous ablation techniques were described for osteoid osteoma management. The successful experience from these resulted in further percutaneous image-guided techniques being attempted, and in other benign bone tumor types. In this article, we present the most common benign bone tumors and describe the available results for the percutaneous treatment of these lesions.


1992 ◽  
Vol 41 (2) ◽  
pp. 536-539
Author(s):  
Makoto Okuno ◽  
Takeshi Minamizaki ◽  
Atsushi Yamamoto ◽  
Kichizo Yamamoto

2021 ◽  
Vol 27 (4) ◽  
pp. 441-445
Author(s):  
P. Lascombes ◽  
◽  
L. Mainard-Simard ◽  
◽  

Introduction The chondromas are a cartilaginous proliferation of mature appearance and moderate size, reason why these tumors are regarded more like hamartomas than real benign tumor. Chondromas represent 10 to 12 % of benign bone tumors. Any bone of an enchondral ossification may be involved. Several bones can be involved, and the disease is called “chondromatosis”. In the review we describe clinical and radiological findings of this pathology as well as indications for reconstructive surgery. Material and methods The review is dedicated to isolated chondromas, periosteal and extraskeletal chondromas, chondromatosis. Results The aspects of epidemiology, clinical presentation, radiology, MRI, prognosis, indications and methods of surgical treatment have been described in the article for each types of chondroma and enchondromatosis. Conclusion Chondromas are benign bone tumors which may be responsible of pathologic fractures. Their surgical treatment consists in curettage and bone grafting or bone-cement filling with or without osteosynthesis. Multiple enchondromatosis should be considered as an osteochondrodysplasia. Its treatment is not the treatment of the multiple chondromas themselves, but of the bone deformities and length discrepancy induced by the disorder. The transformation of some tumors in chondrosarcomas in adolescence or adulthood needs a strict follow up of these patients.


2001 ◽  
Vol 39 (4) ◽  
pp. 673-699 ◽  
Author(s):  
Shannon L. Miller ◽  
Fredric A. Hoffer

Open Medicine ◽  
2018 ◽  
Vol 13 (1) ◽  
pp. 487-492 ◽  
Author(s):  
Daniel Kotrych ◽  
Szymon Korecki ◽  
Paweł Ziętek ◽  
Bartosz Kruk ◽  
Agnieszka Kruk ◽  
...  

AbstractBackground: CERAMENT™|BONE VOID FILLER is an injectable and moldable ceramic bone substitute material intended for bone voids. The material consists of hydroxyapatite and calcium sulfate hemihydrate. The aim of this study is to present the first long-term results following open curettage of benign bone tumors and tumor-like lesions and void filling with this novel injectable and synthetic bone graft. Methods: Thirty three patients were enrolled into the study between June 2013 and October 2014 .Totally, we treated 24 women and 9 men with a median age of 47 years (range: 22-74). All patients suffered from primary musculoskeletal system disorders (enchondroma 63,6%, giant cell tumor 18%, aneurysmal bone cyst 9%, fibrous dysplasia 9%, Gaucher disease 3%). We performed curettage of pathological lesions, then the bone substitute was administered by means of needle to the void. Results: The average follow-up was 13 months (range: 2-13 months, median 10 months). No metastasis or recurrence had been detected. We received significant clinical improvement relating to VAS, MSTS, and oncological results. Conclusions: The results of our study report that CERAMENT can be successfully used as a bone substitute in patients with various bone diseases, as well as benign bone tumors. CERAMENT can provide an effective and long-term solution for reconstructive procedures following curettage of bone tumors and tumor like lesions.


2010 ◽  
pp. 48-49
Author(s):  
Javad Parvizi ◽  
Gregory K. Kim

Sign in / Sign up

Export Citation Format

Share Document